EHCNYSEServices-HospitalsFiscal year ends December 31
Encompass Health Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$121.71−6.16 (-4.82%)
Close on Oct 19, 2026
- Market cap
- $12.17B
- P/E (TTM)
- 19.8
- Dividend yield
- 0.59%
Encompass Health Corp revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q2 22 | TTM Q1 22 | TTM Q4 21 | TTM Q3 21 | TTM Q2 21 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inpatient Rehabilitation | $6.21B | $6.07B | $5.94B | $5.80B | $5.67B | $5.51B | $5.37B | – | – | – | – | – | 100.0% | +9.5% |
| Home Health and Hospice | – | – | – | – | – | – | – | $1.09B | $1.11B | $1.11B | $1.11B | $1.11B | – | – |
| Inpatient Rehabilitation | – | – | – | – | – | – | – | $4.18B | $4.11B | $4.02B | $3.91B | $3.79B | – | – |
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q2 22 | TTM Q1 22 | TTM Q4 21 | TTM Q3 21 | TTM Q2 21 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inpatient | $6.01B | $5.87B | $5.76B | $5.62B | $5.51B | $5.37B | $5.23B | – | – | – | – | – | 96.8% | +9.0% |
| Outpatient and other | – | – | – | $170.80M | $155.40M | $147.10M | $142.70M | – | – | – | – | – | – | – |
By region
From the segment and revenue-disaggregation notes of Encompass Health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.